骨がん治療の世界市場レポート 2024

骨がん治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.3%の年間複合成長率（CAGR）で15億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、医療政策の変化、患者中心のケアモデルへの移行、遠隔医療と遠隔モニタリングの普及、がん患者数の増加、効果的な治療選択肢の欠如、副作用の蔓延が原因であると考えられます。予測期間中に予想される注目すべき動向には、骨がんに対する意識向上を目的とした政府の取り組み、医療機器の技術進歩、研究開発活動の活発化、遺伝子編集技術の探求と進歩、学術界・製薬会社・医療機関との協力の強化などが含まれます。

骨がんの有病率の増加は、骨がん治療市場の拡大を促進すると予想されます。骨がんは、骨組織で発生する一群の悪性腫瘍で構成され、骨内での制御されない細胞分裂と成長が原因で発生します。骨がんの治療戦略は、外科的介入、四肢の温存、痛みの軽減、生活の質の向上、効果的な腫瘍管理など、患者にいくつかの利点を提供することを目的としています。 2023年2月の米国臨床腫瘍学会（ASCO）の報告によると、米国では推定3,970人の新規原発性骨肉腫症例が診断されると予想されており、その内訳は男性が2,160人、女性が1,810人で、400人からの増加を反映しています。したがって、骨がんの有病率の増加は、骨がん治療市場の推進力として機能します。

高齢者人口の増加により、骨がん治療市場の成長はさらに加速すると予想されます。「高齢者人口」という用語は、65歳以上の個人を指します。この疾患は長骨の骨細胞から発生することが多く、年齢とともに発生率が増加する傾向があるため、骨がん治療はこの層にとって不可欠です。高齢者特有のニーズに応え、治療成果を高めるための高度な治療オプションが用意されています。世界保健機関によると、世界では2030年までに6人に1人が60歳以上となり、この年齢層は2050年までに2倍の21億人に増加すると予測されています。英国では下院図書館が2021年6月に次のように報告しています。 2043年までに高齢者人口は総人口の24%を占め、1,740万人に達すると予想されています。したがって、高齢者人口の増加は骨がん治療市場の成長の促進要因として機能します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の骨がん治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 多発性骨髄腫
• 骨肉腫
• 軟骨肉腫
• ユーイング肉腫
• 世界の骨がん治療市場、治療タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 化学療法
• 標的療法
• 放射線療法
• 手術
• その他
• 世界の骨がん治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• ドラッグストア・小売薬局
• オンライン薬局

第7章 地域および国の分析

• 世界の骨がん治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の骨がん治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 骨がん治療市場の競合情勢
• 骨がん治療市場の企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson
  • F. Hoffmann-La Roche Ltd.
  • Merck &Co. Inc.
  • Bayer AG

第31章 その他の大手および革新的な企業

• Novartis AG
• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Amgen Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Astellas Pharma Inc.
• Eisai Co. Ltd.
• Jazz Pharmaceuticals plc
• Incyte Corporation
• Ipsen SA

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

The term 'bone cancer treatment' encompasses the methodologies employed to address and combat bone cancer, a form of cancer originating in bone tissue. This treatment is applied to both primary bone cancers, originating within the bone, and secondary bone cancers, which initiate in another part of the body and subsequently spread to the bone.

The principal categories of bone cancer treatment include multiple myeloma, osteosarcoma, chondrosarcoma, and Ewing sarcoma. Multiple myeloma is a cancer affecting plasma cells, a subtype of white blood cells responsible for antibody production. Treatment modalities for multiple myeloma encompass various approaches such as chemotherapy, targeted therapy, radiation therapy, surgery, and others. The distribution channels for these treatments include hospital pharmacies, drug stores and retail pharmacies, as well as online pharmacies.

The bone cancer treatment market research report is one of a series of new reports from The Business Research Company that provides bone cancer treatment market statistics, including bone cancer treatment industry global market size, regional shares, competitors with a bone cancer treatment market share, detailed bone cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bone cancer treatment industry. This bone cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bone cancer treatment market size has grown strongly in recent years. It will grow from $1.22 billion in 2023 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The historical period's growth can be credited to the development of imaging technologies, enhancements in biopsy techniques, discoveries and advancements in pharmaceuticals, improvements in healthcare infrastructure, and progress in supportive care.

The bone cancer treatment market size is expected to see strong growth in the next few years. It will grow to $1.59 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be ascribed to shifts in healthcare policies, a transition towards patient-centric care models, the proliferation of telemedicine and remote monitoring, a rising number of cancer patients, a lack of effective treatment options, and the prevalence of side effects. Notable trends expected in the forecast period encompass government initiatives aimed at raising awareness about bone cancer, technological advancements in healthcare devices, heightened research and development activities, exploration and progress in gene-editing techniques, and an increased collaboration between academia, pharmaceutical companies, and healthcare institutions.

The increasing prevalence of bone cancer is anticipated to fuel the expansion of the bone cancer treatment market. Bone cancer comprises a group of malignant tumors that originate in bone tissue, resulting from uncontrolled cell division and growth in the bone. Treatment strategies for bone cancer aim to provide several advantages to patients, encompassing surgical interventions, limb preservation, pain relief, improved quality of life, and effective tumor management. As per reports from the American Society of Clinical Oncology (ASCO) in February 2023, an estimated 3,970 new cases of primary bone sarcoma are expected to be diagnosed in the US, with 2,160 in men and 1,810 in women, reflecting an increase from 400 cases in 2013 among individuals aged 15 to 19. Thus, the increasing prevalence of bone cancer acts as a driving force for the bone cancer treatment market.

The growth of the bone cancer treatment market is further expected to be propelled by the rise in the geriatric population. The term 'geriatric population' refers to individuals aged 65 years and older. Bone cancer treatment is essential for this demographic as the disease often originates in the bone cells of long bones, and its incidence tends to increase with age. Advanced treatment options are available to address the specific needs of older adults and enhance treatment outcomes. According to the World Health Organization, globally, by 2030, 1 in 6 people will be 60 or older, and this age group is projected to double to 2.1 billion by 2050. In the UK, the House of Commons Library reported in June 2021 that by 2043, the senior population is expected to constitute 24% of the total population, reaching 17.4 million people. Hence, the rise in the geriatric population serves as a driving factor for the growth of the bone cancer treatment market.

The approval of innovative treatment technologies stands out as a prominent trend gaining traction in the bone cancer treatment market. Major players within the bone cancer treatment sector are strategically focused on developing cutting-edge treatment technologies and obtaining regulatory approvals to fortify their market position. For example, in December 2021, Zetagen Therapeutics, a clinical-stage biopharmaceutical company based in the US, secured breakthrough device recognition from the U.S. Food and Drug Administration (FDA) for its ZetaMet technology. This groundbreaking technology specifically targets metastatic bone cancer, offering a synthetic, small-molecule biologic approach to address such conditions. ZetaMet aims to resolve metastatic bone lesions, inhibit the growth of future lesions, stimulate T cells, and activate cells for healthy bone growth while preventing degradation. Its targeted attachment to the bone surface presents a promising and novel treatment option for patients with metastatic bone cancer.

Major players in the bone cancer treatment market are actively introducing next-generation drugs, including prescription medicines, to gain a competitive advantage. Prescription medicines are pharmaceutical drugs that can only be legally obtained with a written order from a qualified healthcare professional, such as a doctor or dentist. For instance, in September 2023, GSK plc, a UK-based pharmaceutical and biotechnology company, launched Ojjaara (Momelotinib), a prescription medicine designed to treat certain types of myelofibrosis (MF) in adults. Myelofibrosis is a rare form of bone marrow cancer that disrupts the normal production of blood cells. Ojjaara (Momelotinib) offers a novel and effective treatment option for patients grappling with bone cancer and anemia.

In November 2021, Merck & Co. Inc., a US-based pharmaceutical company, completed the acquisition of Acceleron Pharma Inc. for an undisclosed amount. Through this strategic move, Merck & Co. Inc. aims to bolster its extensive track record in addressing cardiovascular illnesses and further support its commercial development strategy, ultimately reaching more patients. Acceleron Pharma Inc. is a US-based clinical-stage biopharmaceutical company specializing in the development of medicines for bone cancer.

Major companies operating in the bone cancer treatment market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Incyte Corporation, Ipsen SA, Kyowa Hakko Kirin Co. Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Karyopharm Therapeutics.

North America was the largest region in the bone cancer treatment market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the bone cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bone cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The bone cancer treatment market includes revenues earned by entities by providing diagnosis and staging, supportive care, multidisciplinary care, biopsy, pain management, and psychosocial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bone Cancer Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bone cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bone cancer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bone cancer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Multiple Myeloma; Osteosarcoma; Chondrosarcoma; Ewing Sarcoma
• 2) By Treatment Type: Chemotherapy; Targeted Therapy; Radiation Therapy; Surgery; Other Treatment Types
• 3) By Distribution Channel: Hospital Pharmacies; Drug Store And Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bone Cancer Treatment Market Characteristics

3. Bone Cancer Treatment Market Trends And Strategies

4. Bone Cancer Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Bone Cancer Treatment Market Size and Growth

• 5.1. Global Bone Cancer Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Bone Cancer Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Bone Cancer Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bone Cancer Treatment Market Segmentation

• 6.1. Global Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Multiple Myeloma
• Osteosarcoma
• Chondrosarcoma
• Ewing Sarcoma
• 6.2. Global Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Chemotherapy
• Targeted Therapy
• Radiation Therapy
• Surgery
• Other Treatment Types
• 6.3. Global Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Drug Store And Retail Pharmacies
• Online Pharmacies

7. Bone Cancer Treatment Market Regional And Country Analysis

• 7.1. Global Bone Cancer Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Bone Cancer Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bone Cancer Treatment Market

• 8.1. Asia-Pacific Bone Cancer Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bone Cancer Treatment Market

• 9.1. China Bone Cancer Treatment Market Overview
• 9.2. China Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bone Cancer Treatment Market

• 10.1. India Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bone Cancer Treatment Market

• 11.1. Japan Bone Cancer Treatment Market Overview
• 11.2. Japan Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bone Cancer Treatment Market

• 12.1. Australia Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bone Cancer Treatment Market

• 13.1. Indonesia Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bone Cancer Treatment Market

• 14.1. South Korea Bone Cancer Treatment Market Overview
• 14.2. South Korea Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bone Cancer Treatment Market

• 15.1. Western Europe Bone Cancer Treatment Market Overview
• 15.2. Western Europe Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bone Cancer Treatment Market

• 16.1. UK Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bone Cancer Treatment Market

• 17.1. Germany Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bone Cancer Treatment Market

• 18.1. France Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bone Cancer Treatment Market

• 19.1. Italy Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bone Cancer Treatment Market

• 20.1. Spain Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bone Cancer Treatment Market

• 21.1. Eastern Europe Bone Cancer Treatment Market Overview
• 21.2. Eastern Europe Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bone Cancer Treatment Market

• 22.1. Russia Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bone Cancer Treatment Market

• 23.1. North America Bone Cancer Treatment Market Overview
• 23.2. North America Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bone Cancer Treatment Market

• 24.1. USA Bone Cancer Treatment Market Overview
• 24.2. USA Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bone Cancer Treatment Market

• 25.1. Canada Bone Cancer Treatment Market Overview
• 25.2. Canada Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bone Cancer Treatment Market

• 26.1. South America Bone Cancer Treatment Market Overview
• 26.2. South America Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bone Cancer Treatment Market

• 27.1. Brazil Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bone Cancer Treatment Market

• 28.1. Middle East Bone Cancer Treatment Market Overview
• 28.2. Middle East Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bone Cancer Treatment Market

• 29.1. Africa Bone Cancer Treatment Market Overview
• 29.2. Africa Bone Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Bone Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Bone Cancer Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bone Cancer Treatment Market Competitive Landscape And Company Profiles

• 30.1. Bone Cancer Treatment Market Competitive Landscape
• 30.2. Bone Cancer Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. F. Hoffmann-La Roche Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck & Co. Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Bone Cancer Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca plc
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Amgen Inc.
• 31.10. Otsuka Pharmaceutical Co. Ltd.
• 31.11. Astellas Pharma Inc.
• 31.12. Eisai Co. Ltd.
• 31.13. Jazz Pharmaceuticals plc
• 31.14. Incyte Corporation
• 31.15. Ipsen SA

32. Global Bone Cancer Treatment Market Competitive Benchmarking

33. Global Bone Cancer Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bone Cancer Treatment Market

35. Bone Cancer Treatment Market Future Outlook and Potential Analysis

• 35.1 Bone Cancer Treatment Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Bone Cancer Treatment Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Bone Cancer Treatment Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer